CEO of VetStem Biopharma, Dr. Robert Harman, to Present Results of Safety Study for Allogeneic Stem Cell Product at Regenerative Medicine Conference

POWAY, Calif. (PRWEB) August 28, 2018 CEO and founder of VetStem Biopharma, Dr. Robert Harman, will be presenting the results of a safety study performed on an allogeneic (donor derived) stem cell product for osteoarthritis in canines at the 2018 North American Veterinary Regenerative Medici…

Source link

Related posts

A fast and effective method for dissecting parasitic spores: myxozoans as an example [METHODS [amp ] TECHNIQUES]


Labs in lockdown


Towards Universal Cell Lines and Tissues Grown from Induced Pluripotent Stem Cells


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World